Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun 29;12(1):44.
doi: 10.1186/s13321-020-00447-2.

DTiGEMS+: drug-target interaction prediction using graph embedding, graph mining, and similarity-based techniques

Affiliations

DTiGEMS+: drug-target interaction prediction using graph embedding, graph mining, and similarity-based techniques

Maha A Thafar et al. J Cheminform. .

Abstract

In silico prediction of drug-target interactions is a critical phase in the sustainable drug development process, especially when the research focus is to capitalize on the repositioning of existing drugs. However, developing such computational methods is not an easy task, but is much needed, as current methods that predict potential drug-target interactions suffer from high false-positive rates. Here we introduce DTiGEMS+, a computational method that predicts Drug-Target interactions using Graph Embedding, graph Mining, and Similarity-based techniques. DTiGEMS+ combines similarity-based as well as feature-based approaches, and models the identification of novel drug-target interactions as a link prediction problem in a heterogeneous network. DTiGEMS+ constructs the heterogeneous network by augmenting the known drug-target interactions graph with two other complementary graphs namely: drug-drug similarity, target-target similarity. DTiGEMS+ combines different computational techniques to provide the final drug target prediction, these techniques include graph embeddings, graph mining, and machine learning. DTiGEMS+ integrates multiple drug-drug similarities and target-target similarities into the final heterogeneous graph construction after applying a similarity selection procedure as well as a similarity fusion algorithm. Using four benchmark datasets, we show DTiGEMS+ substantially improves prediction performance compared to other state-of-the-art in silico methods developed to predict of drug-target interactions by achieving the highest average AUPR across all datasets (0.92), which reduces the error rate by 33.3% relative to the second-best performing model in the state-of-the-art methods comparison.

Keywords: Bioinformatics; Cheminformatics; Drug repositioning; Drug–target interaction; Graph embedding; Heterogenous network; Machine learning; Similarity integration; Similarity-based.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no conflict of interests exist.

Figures

Fig. 1
Fig. 1
DTIs prediction problem depiction
Fig. 2
Fig. 2
Integrating multiple similarities using different functions
Fig. 3
Fig. 3
An illustration of Sum and Max scores for a D–D–D–T path structure
Fig. 4
Fig. 4
DTiGEMS+ prediction Framework. DTIs: drug–target interactions; DD: drug–drug; TT: target–target; FV: feature vector; FSS alg.: forward similarity selection algorithm; SNF fuc: similarity network fusion function; COS similarity: cosine similarity; ML: machine learning
Fig. 5
Fig. 5
Comparison results for DTiGEMS+ and other methods in terms of AUPR using the Yamanishi_08 datasets. The best performing method is indicated in blue, the second-best method in purple, and all other methods in green

References

    1. DiMasi JA, Hansen RW, Grabowski HG. The price of innovation: new estimates of drug development costs. J Health Econ. 2003;22(2):151–185. - PubMed
    1. Yıldırım MA, et al. Drug–target network. Nat Biotechnol. 2007;25:1119. - PubMed
    1. Ashburn TT, Thor KB. Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov. 2004;3(8):673–683. - PubMed
    1. Cheng AC, et al. Structure-based maximal affinity model predicts small-molecule druggability. Nat Biotechnol. 2007;25(1):71–75. - PubMed
    1. Alonso H, Bliznyuk AA, Gready JE. Combining docking and molecular dynamic simulations in drug design. Med Res Rev. 2006;26(5):531–568. - PubMed

LinkOut - more resources